Xerostomia in patients undergoing anticancer therapy

Authors

  • Dr. Venetia Aranha, Dr. Meghana S.M., Dr. Monica Yadav, Dr. Jashika Shroff

Keywords:

Xerostomia, saliva, chemotherapy, radiation damage, salivary glands, saliva substitutes

Abstract

Xerostomia, commonly referred to as dry mouth syndrome, is the result of a decrease or absence of salivary flow, producing mucosal thirst. It is usually caused by systemic autoimmune diseases, including diabetes, neurological disorders and Sjögren's Syndrome, however dry mouth itself is associated with a variety of mood disorders and anxiety disorders and their treatment; and, several medicines are reported to cause xerostomia in at least 10% of users. Therapeutic options include agents that act as saliva and mimic and provide temporary relief of xerostomia, however they do not promote the production of salivary and
are therefore considered a cure for alternative restorations.


Medications such as chemotherapy, pain medication, anti-depressants, diuretics (water pills) can cause xerostomia. When caused by damage to the salivary gland, it can be a lifelong problem and requires patience in treatment. Radiation also causes dry mouth when salivary glands are exposed to radiation.This article summarizes xerostomiain patients undergoing anticancer therapy.

Downloads

Published

2020-10-15

How to Cite

Dr. Venetia Aranha, Dr. Meghana S.M., Dr. Monica Yadav, Dr. Jashika Shroff. (2020). Xerostomia in patients undergoing anticancer therapy. World Journal of Advanced Scientific Research, 3(5), 1 - 15. Retrieved from https://wjasr.in/index.php/wjasr/article/view/175